000 01178 a2200313 4500
005 20250513220226.0
264 0 _c20001228
008 200012s 0 0 eng d
022 _a0268-4705
024 7 _a10.1097/00001573-200003000-00008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaylor, D O
245 0 0 _aImmunosuppressive therapies after heart transplantation: best, better, and beyond.
_h[electronic resource]
260 _bCurrent opinion in cardiology
_cMar 2000
300 _a108-14 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCyclosporine
_xtherapeutic use
650 0 4 _aHeart Transplantation
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLymphocytes
_xdrug effects
650 0 4 _aSirolimus
_xtherapeutic use
650 0 4 _aTacrolimus
_xtherapeutic use
650 0 4 _aTransplantation, Homologous
773 0 _tCurrent opinion in cardiology
_gvol. 15
_gno. 2
_gp. 108-14
856 4 0 _uhttps://doi.org/10.1097/00001573-200003000-00008
_zAvailable from publisher's website
999 _c10910677
_d10910677